Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy

Sponsor
Oslo University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01311440
Collaborator
(none)
75
1
2
76
1

Study Details

Study Description

Brief Summary

In Oslo University Hospital, department of complex epilepsy, offer ketogenic diet to treat children with medically intractable epilepsy. From 2009 we added modified Atkins diet as a treatment option for children up to 18 years.

We now initiate an open, prospective, randomized and controlled study with the aim to test the efficacy of treatment with modified Atkins diet in adults with focal and generalized epilepsy diagnoses, in order to evaluate whether this treatment should be offered to patients on a permanent basis.

Condition or Disease Intervention/Treatment Phase
  • Other: Modified Atkins diet treatment
N/A

Detailed Description

Poorly controlled epilepsy in adults affects health and quality of life in many ways. Within this heterogenous population there are individuals who are motivated for a very strict diet in order to reduce seizures.

Among adults with epilepsy 75 - 80 % are diagnosed with focal epilepsy, while 20 - 25 % have generalized onset of seizures.

We plan to include 92 patients with focal epilepsy diagnosis. Those are randomized into diet and control groups.

During the inclusion period we also treat patients with generalized epilepsy that qualify for participation, but these are not to be randomized, rather they will follow the diet group course. We assume 18 - 23 patients with generalized epilepsy will be included in the project.

Study Design

Study Type:
Interventional
Actual Enrollment :
75 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy - a Controlled, Randomized Trial
Actual Study Start Date :
Mar 1, 2011
Actual Primary Completion Date :
Jun 1, 2017
Actual Study Completion Date :
Jul 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Experimental: Modified Atkins diet treatment

12 weeks of Modified Atkins diet treatment, recording seizures

Other: Modified Atkins diet treatment
Eat a diet containing 16 grams of carbohydrates per day, maximize on fat. Assure sufficient intake of micronutrients.

No Intervention: No intervention

12 weeks seizure record

Outcome Measures

Primary Outcome Measures

  1. Change in seizure frequency [12 weeks]

    All participants record detailed seizure records for 12 weeks prior to the control/diet period. The diet group participants are subsequently treated with modified Atkins diet for 12 weeks, while the control group continue their normal diet and record seizures for another 12 weeks. Seizure records for each participant before and during intervention are compared.

Secondary Outcome Measures

  1. Change in body weight [12 weeks]

  2. Change in standard 3-hrs EEG [12 weeks]

  3. Change in life quality measured by validated questionnaire [12 weeks]

  4. Change in various blood and serum measures [12 weeks]

  5. Change in executive functions measured with validated questionnaire [12 weeks]

  6. Change in seizure strength and severity measured by validated questionnaire [12 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Focal or generalized epilepsy diagnosis

  • More than 3 recordable seizures per month

  • BMI > 18,5

  • Not responded to at least three 3 AEDs

  • 16 years or older

  • Motivated to complete the diet after thorough information

  • Capable of recording seizures

  • Capable of preparing the diet

Exclusion Criteria:
  • Hypercholesterolemia, cardiovascular disease or kidney disease

  • Been on modified Atkins diet for more than one week during the last year

  • Status epilepticus last six months

  • epilepsy surgery or VNS implant last year

  • 4 weeks continuous seizure freedom last 2 months

  • PNES seizures

  • other disease where dietary treatment is contraindicated

  • usage of drugs or supplements that may interfere with diet or AED

  • being pregnant or planning pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Oslo University Hospital, The national Centre for epilepsy Sandvika Bærum Postterminal Norway 1306

Sponsors and Collaborators

  • Oslo University Hospital

Investigators

  • Principal Investigator: Karl Otto Nakken, Oslo University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Magnhild Kverneland, Registered Nutritionist, Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01311440
Other Study ID Numbers:
  • 2010/2326 (REK)
First Posted:
Mar 9, 2011
Last Update Posted:
Sep 19, 2017
Last Verified:
Sep 1, 2017
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Keywords provided by Magnhild Kverneland, Registered Nutritionist, Oslo University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 19, 2017